Medicinova, Inc. (MNOV)
NASDAQ · Manufacturing · Pharmaceutical preparations
$2.54−$0.1100 (−4.15%) on the dayAs of the close; data may be delayed.
MNOV price, last 12 months
Key stats
- Previous close
- $2.65
- Open
- $2.69
- Day range
- $2.53 – $2.70
- 52-week range
- $1.17 – $3.90
- Volume
- 220.9K
- Avg volume (20 days)
- 780.5K
- Market cap
- $127.0M
Performance
1W−23.5%
1M+71.6%
3M+92.4%
6M+78.9%
YTD+93.9%
1Y+103.2%
vs S&P 500, 1Y+86.4 pts
Technicals and fundamentals
About Medicinova, Inc.
MediciNova Inc is a biopharmaceutical company developing novel therapeutics for the treatment of serious diseases with unmet medical needs and a commercial focus on the United States (U.S.) market. It is currently focused on developing MN-166 (ibudilast) for neurological and other disorders such as progressive multiple sclerosis (MS), amyotrophic lateral sclerosis (ALS), chemotherapy-induced peripheral neuropathy, degenerative cervical myelopathy, glioblastoma, and prevention of acute respiratory distress syndrome (ARDS); and MN-001 (tipelukast) for fibrotic and other metabolic disorders such as nonalcoholic fatty liver disease (NAFLD), and hypertriglyceridemia.
- Sector
- Manufacturing
- Industry
- Pharmaceutical preparations
- Listed on
- NASDAQ
- Market cap
- $127.0M